Federal Supply Schedule V797D40071
Award Date
2/15/14
Last Date to Order
2/28/24
Federal Agency
Veterans Integrated Service Network 12
Awardee
Amarin Pharma, Inc.
Ultimate Awardee
Amarin Corporation P L C
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is a $200,000.00 interim agreement with Amarin Pharma, Inc. to provide drugs, pharmaceuticals, and hematology-related products under FSS Schedule 65 IB. The contract has an ultimate completion date of August 30, 2024 and was awarded on March 5, 2024 without any set-aside requirements. The purpose of this multiple-award FSS contract is to...
The Department of Veterans Affairs awarded a multiple-award federal supply schedule contract to Amryt Pharmaceuticals Inc. with a potential value of $225,000. The schedule is for pharmaceuticals and hematology-related products under contract number 65 IB. This enables ordering through September 2028. Additionally, the Department of Veterans Affairs National Acquisition Center awarded a single-award blanket purchase agreement to Amryt Pharmaceuticals with a value of up to $1,000,000. The BPA...
The Department of Veterans Affairs (VA) has awarded Amivas US LLC a five-year, $225,000 multiple-award Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB). This IDV allows VA medical facilities to issue task orders for Amivas' pharmaceuticals and hematology-related products. Amivas, a for-profit limited liability company, has prior experience providing pharmaceuticals and services related to clinical trials and medical research for federal agencies....
The Federal Supply Schedule contract awarded to Supernus Pharmaceuticals, Inc. by Veterans Integrated Service Network 12 is a five-year, $132.6 million agreement to provide drugs, pharmaceuticals, and hematology-related products to the Department of Veterans Affairs. As a multiple award schedule under Federal Supply Schedule 65 IB, this contract enables VA medical facilities to directly order from Supernus's pre-approved catalog of offerings. The contract aims to efficiently deliver...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) to Vifor Pharma Inc., provides for the procurement of drugs, pharmaceuticals, and hematology-related products. The contract has a total ceiling value of $85,200,000 and a period of performance extending to February 28, 2028. As a Federal Supply Schedule contract, this vehicle allows for the efficient procurement of the specified medical and pharmaceutical products by federal agencies, including...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to Omeros Corporation under the Pharmaceuticals and Drugs (FSS-61-IB) master schedule. The contract aims to procure drugs, pharmaceuticals, and hematology-related products for $18.91 million through March 1, 2023. The contract provides access to 65 I B products through established price lists. As a pharmaceutical supply contract...
This Federal Supply Schedule contract, awarded to Mylan Specialty LP by the Department of Veterans Affairs Veterans Health Administration, has a potential value of over $514 million and runs through January 2027. The contract provides for the procurement of pharmaceuticals, drugs, hematology products, and related medical supplies to serve the healthcare needs of veterans. As a multiple award Federal Supply Schedule contract under the Pharmaceuticals and Drugs schedule, this agreement enables...
This Federal Supply Schedule (FSS) contract ID 36F79721D0257 was awarded by the Department of Veterans Affairs (VA) to Amdipharm LIMITED, a for-profit organization. The contract is for Drugs, Pharmaceuticals, & Hematology Related Products under the FSS-61-IB Pharmaceuticals and Drugs schedule, with a ceiling value of $182,000,000 and a period of performance through September 28, 2026. The contract aims to procure a wide range of pharmaceutical and drug products for use by the VA and its 12th...
The Federal Supply Schedule contract is a multiple award IDV under the Pharmaceuticals and Drugs schedule awarded by the Department of Veterans Affairs Veterans Health Administration. The contract aims to provide drugs, pharmaceuticals, and hematology-related products to VHA facilities. The prime contractor is Nabriva Therapeutics US Inc., a for-profit organization. The contract has a potential value of $225,000 and a period of performance through October 15, 2023. No set-asides were used in the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Aquestive Therapeutics, Inc., a for-profit organization, manufacturer of goods, and Subchapter S Corporation. The contract is categorized under FSS-61-IB, Pharmaceuticals and Drugs, with a potential contract value of $225,000.00 and a period of performance from July 1, 2019 to June 30, 2024. The contract seeks to procure drugs, pharmaceuticals,...